TipRanks
Pharmicell Co., Ltd (KR:005690)
:005690
South Korea Market
005690
Pharmicell Co., Ltd
RESEARCH TOOLSreports

Pharmicell Co., Ltd (005690) Income Statement

― Followers

Pharmicell Co., Ltd Income Statement

Last quarter (Q2 2026), Pharmicell Co., Ltd's total revenue was ₩38.98B, an increase of 45.65% from the same quarter last year. In Q2, Pharmicell Co., Ltd's net income was ₩10.38B. See Pharmicell Co., Ltd’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₩ 114.06B₩ 64.85B₩ 56.23B₩ 60.18B₩ 51.81B
Gross Profit
₩ 50.01B₩ 21.33B₩ 14.96B₩ 23.82B₩ 23.17B
Operating Expenses
₩ 16.24B₩ 16.67B₩ 14.00B₩ 14.95B₩ 15.84B
Depreciation and Amortization
₩ 3.03B₩ 3.06B₩ 2.84B₩ 2.19B₩ 1.74B
EBITDA
₩ 36.81B₩ 9.43B₩ 8.44B₩ 8.90B₩ 12.87B
Operating Income
₩ 33.78B₩ 4.66B₩ 951.00M₩ 8.87B₩ 7.86B
Other Income/Expenses
₩ 463.33M₩ 1.61B₩ 3.78B₩ -2.90B₩ 1.59B
Pretax Income
₩ 34.81B₩ 6.26B₩ 4.73B₩ 5.97B₩ 9.45B
Net Income
₩ 40.33B₩ 6.33B₩ 3.58B₩ 8.26B₩ 9.45B
Per Share Metrics
Basic EPS
₩ 671.97₩ 105.51₩ 60.00₩ 137.79₩ 157.66
Diluted EPS
₩ 671.97₩ 105.51₩ 59.63₩ 137.79₩ 157.66
Weighted Average Shares Outstanding
 60.02M 60.00M 59.63M 59.96M 59.95M
Weighted Average Shares Outstanding (Diluted)
 60.02M 60.00M 60.00M 59.96M 59.95M
Currency in KRW

Pharmicell Co., Ltd Earnings and Revenue History